reference/31002828

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31002828

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	2111
issn	1945-7170 0013-7227
issueIdentifier	6
pageRange	2102-2111
publicationName	Endocrinology
startingPage	2102
bibliographicCitation	Shirakawa J, Okuyama T, Yoshida E, Shimizu M, Horigome Y, Tuno T, Hayasaka M, Abe S, Fuse M, Togashi Y, Terauchi Y. Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male mice. Endocrinology. 2014 Jun;155(6):2102–11. doi: 10.1210/en.2013-2032. PMID: 24712877.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4ce5c63f59917832ed3da6f9543ce74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f670cdd7876c3a696d046cad44ca70b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7418f353352c1510eba92417fe140f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aebc7e7d65e6045b383c4f4e1d496cde http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48777d679660b30a61118c90a2de0e07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f1098551f9e24f3ab99720f5bc4d695 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daecbe86d3483b75d0afdf4eda6e14bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_499e14a974327337998be19b25a191ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1619548a7790fd789c484e0a0452b00b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e592967c2fca4354aa7fc0ed2fd6703 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0822-8750 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c94e8dae429981a6da0b889af79846a6
date	2014-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/24712877 https://doi.org/10.1210/en.2013-2032
isPartOf	https://portal.issn.org/resource/ISSN/1945-7170 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3530 https://portal.issn.org/resource/ISSN/0013-7227
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Effects of the Antitumor Drug OSI-906, a Dual Inhibitor of IGF-1 Receptor and Insulin Receptor, on the Glycemic Control, β-Cell Functions, and β-Cell Proliferation in Male Mice
discusses	http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0549134 http://id.nlm.nih.gov/mesh/M0026587 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0018225 http://id.nlm.nih.gov/mesh/M0018605
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017526Q000037 http://id.nlm.nih.gov/mesh/D007093Q000494 http://id.nlm.nih.gov/mesh/D001786Q000187 http://id.nlm.nih.gov/mesh/D050417Q000187 http://id.nlm.nih.gov/mesh/D011972Q000037 http://id.nlm.nih.gov/mesh/D050417Q000166 http://id.nlm.nih.gov/mesh/D011719Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005951 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D050417Q000378 http://id.nlm.nih.gov/mesh/D060888 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fb20d0047710c783a714691f1da3274e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11640390 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10098 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6072 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8075 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf47006963c49a1c0f0a4bfb4adb6589 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8072

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID384783 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID103988

Total number of triples: 67.